Newsfeed – Page 2 of 7 – Kompetenz statt Demenz

Recent study shows: Antibody drugs for Alzheimer’s shrink the brain

Recent study shows: Antibody drugs for Alzheimer’s shrink the brain

By Kerstin Groß-Steinmeyer|2023-07-05T18:40:58+02:005. July 2023|Categories: causes, forms of treatment, medication|

An Australian study found that antibody drugs for Alzheimer's, such as aducanumab and lecanemab, can reduce brain volumes. Despite successful reduction of Alzheimer's-specific amyloid-beta deposits, the benefit of these drugs remains questionable. They slow cognitive decline only slightly and have severe side effects. The study also suggests that these drugs promote the cardinal structural symptom of Alzheimer's disease, brain atrophy. Thus, they increase the risk of brain tissue loss, a direct cause of cognitive decline in Alzheimer's disease.

KsD up to date: messages and news from all over the world

KsD up to date: messages and news from all over the world

By Kerstin Groß-Steinmeyer|2023-06-18T20:32:07+02:007. June 2023|Categories: causes, forms of treatment, prevention|

At regular time intervals, we would like to draw your attention to current reports on the Internet that are closely related to our core topic of lifestyle-oriented and self-responsible prevention and treatment of dementia and its relevance. The opinions expressed there should stimulate a critical exchange of views. They do not necessarily reflect the positions we hold, but in all cases they enrich the basis for discussion. t the end of each press article, we refer to our scientifically based KsD articles - please make up your own mind!

New Theory in dementia research: could fructose trigger Alzheimer’s?

New Theory in dementia research: could fructose trigger Alzheimer’s?

By Kerstin Groß-Steinmeyer|2023-04-18T14:36:18+02:0019. April 2023|Categories: causes, nutrition, prevention|Tags: carbohydrates, sugars|

The fact that fructose hardly raises blood glucose levels due to its low glycemic index and is largely metabolized independently of insulin has led to the assumption in the past that it has a beneficial effect on health. New studies prove that fructose is less beneficial than previously thought.

Highly processed foods and neuronal health: is there also a link with other neurodegenerative diseases such as multiple sclerosis?

Highly processed foods and neuronal health: is there also a link with other neurodegenerative diseases such as multiple sclerosis?

By Maria Beatriz Harouche|2023-03-21T14:11:49+01:0022. March 2023|Categories: causes, multiple sclerosis, nutrition, prevention|

Recently, we reported on "Knowledge stops dementia" about (ultra)processed food, also known as fast food, and the associated risk to [...]

Step by step to dementia prevention – those who walk daily protect their brains

Step by step to dementia prevention – those who walk daily protect their brains

By Maria Beatriz Harouche|2023-03-21T14:11:50+01:0022. February 2023|Categories: causes, exercise, prevention|

A rolling stone gathers no moss. This simple saying also hits the nail on the head when it comes to dementia prevention. This is now also confirmed by a large number of scientific studies. New findings show that there is far more leeway in the recommendations for daily exercise routines than previously assumed.

KsD up to date: messages and news from all over the world

KsD up to date: messages and news from all over the world

By Kerstin Groß-Steinmeyer|2023-03-21T14:11:50+01:0025. January 2023|Categories: causes, forms of treatment, prevention|

Since 2022 the team of the project "Knowledge stops Dementia" started to refer on a regular base to current contributions from the world wide web which have a close relation to our core topic, the early detection of individual risk factors and thus the lifestyle-oriented and self-responsible prevention and treatment of dementia-related diseases. The opinions expressed in the following articles should serve as a stimulus for critical discussion. They do not necessarily correspond to the positions we hold, but in all cases, they enrich the basis for discussion. Occasionally, we also refer to current freely available studies at the end – please make up your own mind!

The new Alzheimer’s drug Lecanemab: miracle drug or flop? Take a look for yourself!

The new Alzheimer’s drug Lecanemab: miracle drug or flop? Take a look for yourself!

By Kerstin Groß-Steinmeyer|2023-01-24T19:36:33+01:0014. December 2022|Categories: causes, forms of treatment, medication|

The situation is escalating: While the number of Alzheimer's patients in Germany and worldwide is increasing dramatically, a pharmacological [...]

How environmental toxins can affect the human brain and increase the risk of Alzheimer’s disease

How environmental toxins can affect the human brain and increase the risk of Alzheimer’s disease

By Maria Beatriz Harouche|2023-03-21T14:11:50+01:009. November 2022|Categories: causes, prevention, toxin reduction|

The link between exposure to environmental pollutants and Alzheimer's disease, although not fully proven, has been documented in numerous scientific studies for years. People who are exposed to pollutants and have higher blood levels of toxic and harmful substances have a higher risk of developing dementia.

New focus in dementia research: Ultra-processed foods as risk factor

New focus in dementia research: Ultra-processed foods as risk factor

By Kerstin Groß-Steinmeyer|2023-03-21T14:11:51+01:0012. October 2022|Categories: causes, micronutrient deficiencies, nutrition, prevention, uncategorized|

Nutrition-related dementia research has generated a flood of promising data in recent years, focusing on the amount of certain nutrients or ingredients in the diet. More recently, many people's diets have changed, and researchers are beginning to focus on a different component of the diet: Ultra-processed foods, also known as fast foods.

Breaking News: Possible fraud in Alzheimer’s research puts the “Amyloid-plaque theory” into question!

Breaking News: Possible fraud in Alzheimer’s research puts the “Amyloid-plaque theory” into question!

By Maria Beatriz Harouche|2023-03-21T14:11:51+01:0014. September 2022|Categories: drugs, forms of treatment, medication, prevention|Tags: Prevention, Research, Treatment, β-Amyloid|

The Amyloid theory is accepted to date as the major justification for the development of Alzheimer's disease and has guided the focus of research in this area. According to this theory, the formation of amyloid plaques, often also referred to as senile plaques, that is, abnormal deposits of the amyloid beta protein (Aβ) in the brain would be the direct cause for the symptoms of this type of dementia. This theory was born in the first description of the disease in 1907, when Alois Alzheimer found a large amount of those plaques distributed in the brain of his famous patient Auguste Deter, when examining her brain after her death. In 1984, Aβ was identified as the main component of the plaques.